Kura Oncology Inc [KURA] stock prices are up 2.51% to $20.40 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KURA shares have gain 0.20% over the last week, with a monthly amount drifted -8.56%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Kura Oncology Inc [NASDAQ: KURA] stock has seen the most recent analyst activity on December 22, 2023, when Mizuho initiated its Buy rating and assigned the stock a price target of $26. Previously, BofA Securities started tracking the stock with Buy rating on August 11, 2023, and set its price target to $31. On July 27, 2023, Scotiabank initiated with a Sector Perform rating and assigned a price target of $10.50 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $31 on May 17, 2023. Stifel initiated its recommendation with a Buy and recommended $25 as its price target on January 31, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on July 12, 2022, and assigned it a price target of $30. In a note dated February 15, 2022, Jefferies initiated an Buy rating and provided a target price of $35 on this stock.
The stock price of Kura Oncology Inc [KURA] has been fluctuating between $7.41 and $24.17 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Kura Oncology Inc [NASDAQ: KURA] shares were valued at $20.40 at the most recent close of the market. An investor can expect a potential return of 27.45% based on the average KURA price forecast.
Analyzing the KURA fundamentals
Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -127.67%, Pretax Profit Margin comes in at -120.18%, and Net Profit Margin reading is -117.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is 1.44 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 20.09 points at the first support level, and at 19.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.67, and for the 2nd resistance point, it is at 20.93.
Ratios To Look Out For
It’s worth pointing out that Kura Oncology Inc [NASDAQ:KURA]’s Current Ratio is 12.26. As well, the Quick Ratio is 12.26, while the Cash Ratio is 1.06.
Transactions by insiders
Recent insider trading involved DALE STEPHEN, Chief Medical Officer, that happened on Jan 30 ’24 when 4825.0 shares were sold. Chief Medical Officer, DALE STEPHEN completed a deal on Jan 29 ’24 to sell 7158.0 shares. Meanwhile, SVP, Finance & Accounting DOYLE THOMAS JAMES sold 2318.0 shares on Jan 29 ’24.
